This report aims to provide a comprehensive presentation of the global market for Pet Anthelmintic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pet Anthelmintic Drugs. This report contains market size and forecasts of Pet Anthelmintic Drugs in global, including the following market information:
Global Pet Anthelmintic Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Pet Anthelmintic Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
External Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Pet Anthelmintic Drugs include Elanco, Boehringer Ingelheim, Ceva Sante Animale, Chanelle Group, Dechra, Durvet, First Priority, Jeffers and Manna Pro Products, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pet Anthelmintic Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pet Anthelmintic Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Pet Anthelmintic Drugs Market Segment Percentages, by Type, 2022 (%)
External
Internal
Composite
Injection
Global Pet Anthelmintic Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Pet Anthelmintic Drugs Market Segment Percentages, by Application, 2022 (%)
Dog
Cat
Others
Global Pet Anthelmintic Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Pet Anthelmintic Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pet Anthelmintic Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Pet Anthelmintic Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Elanco
Boehringer Ingelheim
Ceva Sante Animale
Chanelle Group
Dechra
Durvet
First Priority
Jeffers
Manna Pro Products
Merck Animal Health
Ourofino
TTK Healthcare
Vetoquinol
Virbac
Zoetis
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pet Anthelmintic Drugs, market overview.
Chapter 2: Global Pet Anthelmintic Drugs market size in revenue.
Chapter 3: Detailed analysis of Pet Anthelmintic Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pet Anthelmintic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Pet Anthelmintic Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pet Anthelmintic Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pet Anthelmintic Drugs Overall Market Size
2.1 Global Pet Anthelmintic Drugs Market Size: 2022 VS 2029
2.2 Global Pet Anthelmintic Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Pet Anthelmintic Drugs Players in Global Market
3.2 Top Global Pet Anthelmintic Drugs Companies Ranked by Revenue
3.3 Global Pet Anthelmintic Drugs Revenue by Companies
3.4 Top 3 and Top 5 Pet Anthelmintic Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Pet Anthelmintic Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Pet Anthelmintic Drugs Players in Global Market
3.6.1 List of Global Tier 1 Pet Anthelmintic Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Pet Anthelmintic Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Pet Anthelmintic Drugs Market Size Markets, 2022 & 2029
4.1.2 External
4.1.3 Internal
4.1.4 Composite
4.1.5 Injection
4.2 By Type - Global Pet Anthelmintic Drugs Revenue & Forecasts
4.2.1 By Type - Global Pet Anthelmintic Drugs Revenue, 2018-2023
4.2.2 By Type - Global Pet Anthelmintic Drugs Revenue, 2024-2029
4.2.3 By Type - Global Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Pet Anthelmintic Drugs Market Size, 2022 & 2029
5.1.2 Dog
5.1.3 Cat
5.1.4 Others
5.2 By Application - Global Pet Anthelmintic Drugs Revenue & Forecasts
5.2.1 By Application - Global Pet Anthelmintic Drugs Revenue, 2018-2023
5.2.2 By Application - Global Pet Anthelmintic Drugs Revenue, 2024-2029
5.2.3 By Application - Global Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Pet Anthelmintic Drugs Market Size, 2022 & 2029
6.2 By Region - Global Pet Anthelmintic Drugs Revenue & Forecasts
6.2.1 By Region - Global Pet Anthelmintic Drugs Revenue, 2018-2023
6.2.2 By Region - Global Pet Anthelmintic Drugs Revenue, 2024-2029
6.2.3 By Region - Global Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Pet Anthelmintic Drugs Revenue, 2018-2029
6.3.2 US Pet Anthelmintic Drugs Market Size, 2018-2029
6.3.3 Canada Pet Anthelmintic Drugs Market Size, 2018-2029
6.3.4 Mexico Pet Anthelmintic Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Pet Anthelmintic Drugs Revenue, 2018-2029
6.4.2 Germany Pet Anthelmintic Drugs Market Size, 2018-2029
6.4.3 France Pet Anthelmintic Drugs Market Size, 2018-2029
6.4.4 U.K. Pet Anthelmintic Drugs Market Size, 2018-2029
6.4.5 Italy Pet Anthelmintic Drugs Market Size, 2018-2029
6.4.6 Russia Pet Anthelmintic Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Pet Anthelmintic Drugs Market Size, 2018-2029
6.4.8 Benelux Pet Anthelmintic Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Pet Anthelmintic Drugs Revenue, 2018-2029
6.5.2 China Pet Anthelmintic Drugs Market Size, 2018-2029
6.5.3 Japan Pet Anthelmintic Drugs Market Size, 2018-2029
6.5.4 South Korea Pet Anthelmintic Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Pet Anthelmintic Drugs Market Size, 2018-2029
6.5.6 India Pet Anthelmintic Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Pet Anthelmintic Drugs Revenue, 2018-2029
6.6.2 Brazil Pet Anthelmintic Drugs Market Size, 2018-2029
6.6.3 Argentina Pet Anthelmintic Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Pet Anthelmintic Drugs Revenue, 2018-2029
6.7.2 Turkey Pet Anthelmintic Drugs Market Size, 2018-2029
6.7.3 Israel Pet Anthelmintic Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Pet Anthelmintic Drugs Market Size, 2018-2029
6.7.5 UAE Pet Anthelmintic Drugs Market Size, 2018-2029
7 Pet Anthelmintic Drugs Companies Profiles
7.1 Elanco
7.1.1 Elanco Company Summary
7.1.2 Elanco Business Overview
7.1.3 Elanco Pet Anthelmintic Drugs Major Product Offerings
7.1.4 Elanco Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.1.5 Elanco Key News & Latest Developments
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim Pet Anthelmintic Drugs Major Product Offerings
7.2.4 Boehringer Ingelheim Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.2.5 Boehringer Ingelheim Key News & Latest Developments
7.3 Ceva Sante Animale
7.3.1 Ceva Sante Animale Company Summary
7.3.2 Ceva Sante Animale Business Overview
7.3.3 Ceva Sante Animale Pet Anthelmintic Drugs Major Product Offerings
7.3.4 Ceva Sante Animale Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.3.5 Ceva Sante Animale Key News & Latest Developments
7.4 Chanelle Group
7.4.1 Chanelle Group Company Summary
7.4.2 Chanelle Group Business Overview
7.4.3 Chanelle Group Pet Anthelmintic Drugs Major Product Offerings
7.4.4 Chanelle Group Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.4.5 Chanelle Group Key News & Latest Developments
7.5 Dechra
7.5.1 Dechra Company Summary
7.5.2 Dechra Business Overview
7.5.3 Dechra Pet Anthelmintic Drugs Major Product Offerings
7.5.4 Dechra Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.5.5 Dechra Key News & Latest Developments
7.6 Durvet
7.6.1 Durvet Company Summary
7.6.2 Durvet Business Overview
7.6.3 Durvet Pet Anthelmintic Drugs Major Product Offerings
7.6.4 Durvet Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.6.5 Durvet Key News & Latest Developments
7.7 First Priority
7.7.1 First Priority Company Summary
7.7.2 First Priority Business Overview
7.7.3 First Priority Pet Anthelmintic Drugs Major Product Offerings
7.7.4 First Priority Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.7.5 First Priority Key News & Latest Developments
7.8 Jeffers
7.8.1 Jeffers Company Summary
7.8.2 Jeffers Business Overview
7.8.3 Jeffers Pet Anthelmintic Drugs Major Product Offerings
7.8.4 Jeffers Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.8.5 Jeffers Key News & Latest Developments
7.9 Manna Pro Products
7.9.1 Manna Pro Products Company Summary
7.9.2 Manna Pro Products Business Overview
7.9.3 Manna Pro Products Pet Anthelmintic Drugs Major Product Offerings
7.9.4 Manna Pro Products Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.9.5 Manna Pro Products Key News & Latest Developments
7.10 Merck Animal Health
7.10.1 Merck Animal Health Company Summary
7.10.2 Merck Animal Health Business Overview
7.10.3 Merck Animal Health Pet Anthelmintic Drugs Major Product Offerings
7.10.4 Merck Animal Health Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.10.5 Merck Animal Health Key News & Latest Developments
7.11 Ourofino
7.11.1 Ourofino Company Summary
7.11.2 Ourofino Business Overview
7.11.3 Ourofino Pet Anthelmintic Drugs Major Product Offerings
7.11.4 Ourofino Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.11.5 Ourofino Key News & Latest Developments
7.12 TTK Healthcare
7.12.1 TTK Healthcare Company Summary
7.12.2 TTK Healthcare Business Overview
7.12.3 TTK Healthcare Pet Anthelmintic Drugs Major Product Offerings
7.12.4 TTK Healthcare Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.12.5 TTK Healthcare Key News & Latest Developments
7.13 Vetoquinol
7.13.1 Vetoquinol Company Summary
7.13.2 Vetoquinol Business Overview
7.13.3 Vetoquinol Pet Anthelmintic Drugs Major Product Offerings
7.13.4 Vetoquinol Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.13.5 Vetoquinol Key News & Latest Developments
7.14 Virbac
7.14.1 Virbac Company Summary
7.14.2 Virbac Business Overview
7.14.3 Virbac Pet Anthelmintic Drugs Major Product Offerings
7.14.4 Virbac Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.14.5 Virbac Key News & Latest Developments
7.15 Zoetis
7.15.1 Zoetis Company Summary
7.15.2 Zoetis Business Overview
7.15.3 Zoetis Pet Anthelmintic Drugs Major Product Offerings
7.15.4 Zoetis Pet Anthelmintic Drugs Revenue in Global Market (2018-2023)
7.15.5 Zoetis Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Pet Anthelmintic Drugs Market Opportunities & Trends in Global Market
Table 2. Pet Anthelmintic Drugs Market Drivers in Global Market
Table 3. Pet Anthelmintic Drugs Market Restraints in Global Market
Table 4. Key Players of Pet Anthelmintic Drugs in Global Market
Table 5. Top Pet Anthelmintic Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Pet Anthelmintic Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Pet Anthelmintic Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Pet Anthelmintic Drugs Product Type
Table 9. List of Global Tier 1 Pet Anthelmintic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Pet Anthelmintic Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Pet Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Pet Anthelmintic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Pet Anthelmintic Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Pet Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Pet Anthelmintic Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Pet Anthelmintic Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Pet Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Pet Anthelmintic Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Pet Anthelmintic Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Pet Anthelmintic Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Pet Anthelmintic Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Pet Anthelmintic Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Pet Anthelmintic Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Pet Anthelmintic Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Elanco Company Summary
Table 31. Elanco Pet Anthelmintic Drugs Product Offerings
Table 32. Elanco Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Elanco Key News & Latest Developments
Table 34. Boehringer Ingelheim Company Summary
Table 35. Boehringer Ingelheim Pet Anthelmintic Drugs Product Offerings
Table 36. Boehringer Ingelheim Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Boehringer Ingelheim Key News & Latest Developments
Table 38. Ceva Sante Animale Company Summary
Table 39. Ceva Sante Animale Pet Anthelmintic Drugs Product Offerings
Table 40. Ceva Sante Animale Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Ceva Sante Animale Key News & Latest Developments
Table 42. Chanelle Group Company Summary
Table 43. Chanelle Group Pet Anthelmintic Drugs Product Offerings
Table 44. Chanelle Group Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Chanelle Group Key News & Latest Developments
Table 46. Dechra Company Summary
Table 47. Dechra Pet Anthelmintic Drugs Product Offerings
Table 48. Dechra Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Dechra Key News & Latest Developments
Table 50. Durvet Company Summary
Table 51. Durvet Pet Anthelmintic Drugs Product Offerings
Table 52. Durvet Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Durvet Key News & Latest Developments
Table 54. First Priority Company Summary
Table 55. First Priority Pet Anthelmintic Drugs Product Offerings
Table 56. First Priority Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. First Priority Key News & Latest Developments
Table 58. Jeffers Company Summary
Table 59. Jeffers Pet Anthelmintic Drugs Product Offerings
Table 60. Jeffers Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Jeffers Key News & Latest Developments
Table 62. Manna Pro Products Company Summary
Table 63. Manna Pro Products Pet Anthelmintic Drugs Product Offerings
Table 64. Manna Pro Products Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Manna Pro Products Key News & Latest Developments
Table 66. Merck Animal Health Company Summary
Table 67. Merck Animal Health Pet Anthelmintic Drugs Product Offerings
Table 68. Merck Animal Health Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. Merck Animal Health Key News & Latest Developments
Table 70. Ourofino Company Summary
Table 71. Ourofino Pet Anthelmintic Drugs Product Offerings
Table 72. Ourofino Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 73. Ourofino Key News & Latest Developments
Table 74. TTK Healthcare Company Summary
Table 75. TTK Healthcare Pet Anthelmintic Drugs Product Offerings
Table 76. TTK Healthcare Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 77. TTK Healthcare Key News & Latest Developments
Table 78. Vetoquinol Company Summary
Table 79. Vetoquinol Pet Anthelmintic Drugs Product Offerings
Table 80. Vetoquinol Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 81. Vetoquinol Key News & Latest Developments
Table 82. Virbac Company Summary
Table 83. Virbac Pet Anthelmintic Drugs Product Offerings
Table 84. Virbac Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 85. Virbac Key News & Latest Developments
Table 86. Zoetis Company Summary
Table 87. Zoetis Pet Anthelmintic Drugs Product Offerings
Table 88. Zoetis Pet Anthelmintic Drugs Revenue (US$, Mn) & (2018-2023)
Table 89. Zoetis Key News & Latest Developments
List of Figures
Figure 1. Pet Anthelmintic Drugs Segment by Type in 2022
Figure 2. Pet Anthelmintic Drugs Segment by Application in 2022
Figure 3. Global Pet Anthelmintic Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Pet Anthelmintic Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Pet Anthelmintic Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Pet Anthelmintic Drugs Revenue in 2022
Figure 8. By Type - Global Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Pet Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Pet Anthelmintic Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
Figure 16. US Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
Figure 28. China Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Pet Anthelmintic Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Pet Anthelmintic Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Elanco Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Boehringer Ingelheim Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Ceva Sante Animale Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Chanelle Group Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Dechra Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Durvet Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. First Priority Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Jeffers Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Manna Pro Products Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Merck Animal Health Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Ourofino Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. TTK Healthcare Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Vetoquinol Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Virbac Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Zoetis Pet Anthelmintic Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
